Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05184855 · ClinicalTrials.gov registry record · NA

Blueberries and Exercise Inflammation

A NA study, sponsored by Appalachian State University.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT05184855 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 49 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05184855, a NA study, has completed, sponsored by Appalachian State University.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

The purpose of this study is to determine if 2-weeks supplementation with blueberries (1 cup/day) compared to placebo can mitigate muscle soreness and damage, and improve inflammation resolution and metabolic recovery during a 5-day period after engaging in an acute, 90-minute bout of eccentric exercise. The primary outcome will be plasma oxylipin levels, extending previously collected data showing that blueberry ingestion decreases post-exercise oxylipins generated from cytochrome P450 enzymes.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Blueberry

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2021-12-01
Est. Completion 2022-08-15
Phase NA

Sponsor

Appalachian State University

37 total trials

What the Registry Record Tells You About NCT05184855

The ClinicalTrials.gov registry entry for NCT05184855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT05184855 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05184855 about?

NCT05184855 is a clinical study titled "Blueberries and Exercise Inflammation". The purpose of this study is to determine if 2-weeks supplementation with blueberries (1 cup/day) compared to placebo can mitigate muscle soreness and damage, and improve inflammation resolution and metabolic recovery during a 5-day period after engaging in an acute, 90-minute bout of eccentric exer...

What is the current status of trial NCT05184855?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2021-12-01. Estimated completion is 2022-08-15.

What interventions are being tested in trial NCT05184855?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Blueberry (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05184855?

This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.